Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

Eggington, S., Tappenden, P., Pandor, A. et al. (5 more authors) (2006) Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British Journal of Cancer, 95 (9). 1195 - 1201. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Eggington, S.
  • Tappenden, P.
  • Pandor, A.
  • Paisley, S.
  • Saunders, M.
  • Seymour, M.
  • Sutcliffe, P.
  • Chilcott, J.
Copyright, Publisher and Additional Information: © 2006. Cancer Research UK . Reproduced in accordance with the publisher's self-archiving policy.
Keywords: oxaliplatin; capecitabine; adjuvant chemotherapy; colonic neoplasms; economic evaluation; coloretical-cancer; follow-up; recomendations; fluorouracil; chemotherapy; carcinoma; resection; therapy
Dates:
  • Published: 6 November 2006
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 Sep 2014 15:34
Last Modified: 28 Jul 2015 15:42
Published Version: http://dx.doi.org/10.1038/sj.bjc.6603348
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6603348

Share / Export

Statistics